Minimum cochlear dose impacts hearing after radiosurgery for sporadic vestibular schwannoma
The minimum cochlear dose impacts hearing outcomes after SRS for VS and should be considered in radiosurgical treatment planning. In this cohort, the mean cochlear dose was only associated with hearing outcomes in the subgroup of patients with class B hearing at SRS.
Authors
- Eric E. Babajanian (ORCID: https://orcid.org/0000-0003-2070-4518)
- Karl R. Khandalavala (ORCID: https://orcid.org/0000-0001-6947-5571)
- Ramin A. Morshed (ORCID: https://orcid.org/0000-0001-8464-6041)
- Ghazal S. Daher (ORCID: https://orcid.org/0000-0001-5013-3555)
- Christine M. Lohse (ORCID: https://orcid.org/0000-0001-9888-7495)
- John P. Marinelli (ORCID: https://orcid.org/0000-0003-2350-8942)
- James R. Dornhoffer (ORCID: https://orcid.org/0000-0001-8871-8655)
- Paul D. Brown (ORCID: https://orcid.org/0000-0003-0022-4533)
- Michael J. Link
- Matthew L. Carlson
Institutions
- Radiation Oncology Associates (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of neurosurgery
- Published
- 2024-11-01
- DOI
- https://doi.org/10.3171/2024.7.jns24789
- Citations
- 1
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.39